InsidersTradesSigma
Track the 润达医疗 share price and the full insider trade history of the company, a publicly traded company based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 润达医疗 has published 11 insider filings. Market capitalisation: €6.4bn. The latest transaction was filed on 17 June 2026 (Sale). Among the most active insiders: 陈政. All data is free.
11
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€11m
11 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,507 of 28,985 companies
32.4
score / 100
Value44
Quality21
FCF yld6.5%
Earn yld-9.2%
EV/EBITDA·
ROE-9.5%
Gross mgn21%
Net mgn-7.8%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 17 June 2026
Declarations11 total
1,267,700 sharesA股XSHGSSE:173000006285450980
11 of 11 declarations
About 润达医疗
润达医疗 is a company in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and manufacturing of medical devices and innovative health solutions.